Hikma Buys Injectables Specialist Custopharm In $400m+ Deal

Deal To Acquire California-Based Firm Will Bolster Hikma’s US Injectables Business

 
• By David Wallace
  
Injectables Vials Syringe
Hikma has agreed a $400m+ deal for sterile injectables specialist Custopharm • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business